Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Branded Life After Lipitor: Pharma Targets Unmet Needs In Dyslipidemia

Apr 23 2012

Related Content

Genzyme/Isis On Track To Submit Cholesterol Drug Mipomersen In 1H 2011

Sep 01 2010

Statin Labeling Changes Include Class Warning About Glucose Effects

Feb 28 2012

Sanofi/Genzyme And Isis Submit <em>Kynamro</em> For Lowering Cholesterol

Mar 30 2012

No Surprises From ENHANCE At ACC Mean Vytorin Hopes Hang On IMPROVE-IT

Apr 07 2008

As It Soaks Up Good Trial Results, Amarin Ponders Partners - Or None

Apr 21 2011

Regeneron/Sanofi’s Long-Term Alliances Begin Bearing Fruit

Apr 02 2012

Merck’s Anacetrapib Debut Many Years Away, Despite Robust Phase III Data

Nov 22 2010

Pfizer’s Lipitor Extension Shot Down By Failure Of Torcetrapib Silver Bullet

Dec 11 2006

Related Companies

Pfizer Inc.

Merck & Co., Inc.

Boehringer Ingelheim GmbH

Bristol Myers Squibb Company

Johnson & Johnson

Bayer AG

Regeneron Pharmaceuticals, Inc.

Sanofi

US Department of Health and Human Services

Amarin Corp plc

Omthera Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc.

Sanofi

Merck & Co., Inc.

Eli Lilly and Company

Dr. Reddy's Laboratories Ltd.

Roche Holding AG

Karo Pharma AB

Amgen, Inc.

Pfizer Inc.

Alnylam Pharmaceuticals Inc.

Roche Holding AG

Ionis Pharmaceuticals, Inc.

Sanofi Genzyme

BASF AG

GSK plc

Amarin Corp plc

Omthera Pharmaceuticals, Inc.

Amgen, Inc.

Alnylam Pharmaceuticals Inc.

University of California, Los Angeles

Eli Lilly and Company

University of California San Francisco

Mayo Clinic

Additional Topics

Clinical Trials Advertising, Marketing & Sales BioPharmaceutical

More from In Vivo Archive

More from In Vivo

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window